Combination and Monotherapy for Familial Hypercholesterolaemia
Colesevelam (Cholestagel®) is NOT recommended as combination or monotherapy for familial hypercholesterolaemia. Clinical evidence indicates that the drug is poorly tolerated and the trials were weak in significant areas.
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria